9F1 — Diagonal Bio AB Share Price
0.000.00%
Last trade - 00:00- €5.11m
- €4.85m
- SEK0.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.8 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2,582.44 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -54.43% | ||
| Return on Equity | -44.49% | ||
| Operating Margin | -50286.96% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | 0.02 | 0.41 | 0.2 | 0.02 | n/a | n/a | 4.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Diagonal Bio AB is a Sweden-based medical research company. The Company is developing a diagnostic platform (Panviral) for detection of any kind of pathogen. Panviral’s technology is based on rapid isothermal amplification of a pathogen’s genome. Multiple tests can be run in parallel, thereby increasing the sample throughput.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 19th, 2020
- Public Since
- July 16th, 2021
- No. of Employees
- 4
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Frankfurt Stock Exchange
- Shares in Issue
- 679,588,243
- Address
- The Spark, Medicon Village, LUND, 223 81
- Web
- https://diagonalbio.com/
- Phone
- Auditors
- MAZARS
Upcoming Events for 9F1
Similar to 9F1
4Sc AG
Frankfurt Stock Exchange
CureVac NV
Frankfurt Stock Exchange
Medpace Holdings
Frankfurt Stock Exchange
PAION AG
Frankfurt Stock Exchange
Qiagen NV
Frankfurt Stock Exchange
FAQ
What is the Diagonal Bio AB share price?
As of Today at 19:07 UTC, shares in Diagonal Bio AB are trading at €0.01. This share price information is delayed by 15 minutes.
How has the Diagonal Bio AB share price performed this year?
Shares in Diagonal Bio AB last closed at €0.01 and the price had moved by -83.49% over the past 365 days. In terms of relative price strength the Diagonal Bio AB share price has underperformed the FTSE Global All Cap Index by -84.5% over the past year.
What are the analyst and broker recommendations for Diagonal Bio AB?
There is no consensus recommendation for this security.
What is the Diagonal Bio AB dividend yield?
Diagonal Bio AB does not currently pay a dividend.
Does Diagonal Bio AB pay a dividend?
Diagonal Bio AB does not currently pay a dividend.
When does Diagonal Bio AB next pay dividends?
Diagonal Bio AB does not currently pay a dividend.
How do I buy Diagonal Bio AB shares?
To buy shares in Diagonal Bio AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Diagonal Bio AB?
As of the previous close price of €0.01, shares in Diagonal Bio AB had a market capitalisation of €5.11m.
Where are Diagonal Bio AB shares listed?
Here are the trading details for Diagonal Bio AB:
- Country of listing: Germany
- Exchange: FRA
- Ticker Symbol: 9F1
What kind of share is Diagonal Bio AB?
Based on an overall assessment of its quality, value and momentum Diagonal Bio AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Diagonal Bio AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Diagonal Bio AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diagonal Bio AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -79.88%.
As of the last closing price of €0.01, shares in Diagonal Bio AB were trading -73.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Diagonal Bio AB PE Ratio?
The Diagonal Bio AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Diagonal Bio AB?
We do not have data on Diagonal Bio AB's directors